MedPath

Anatomical Shoulder™ Inverse/Reverse Study

Not Applicable
Completed
Conditions
Cuff-tear Arthropathy
Registration Number
NCT02466321
Lead Sponsor
Zimmer, GmbH
Brief Summary

The purpose of this study is to obtain outcomes data on the Anatomical Shoulder™ Inverse/Reverse System by analysis of standard scoring systems and radiographs.

Outcome data will be collected using the following standard scoring systems of which summary statistics will be provided:

• Constant and Murley Score to evaluate clinical parameters such as range of motion, power, level of pain and functional ability.

Detailed Description

This is a multi-centre, non-comparative, prospective post-market surveillance study involving orthopaedic surgeons skilled in shoulder replacement surgery. Each case enrolled will receive an Anatomical Shoulder™ Inverse/Reverse implant. All system components are CE-marked and commercially available. Patients will be selected according to the subject selection criteria.

All patients will undergo pre-operative, intra-operative and post-operative physical examination, radiographic evaluation according to the hospital's routine procedure and collection of quality of life metrics. Follow-up evaluations are to be conducted at either 6 weeks or 6 months (according to the hospital's standard care plan) and thereafter at 1, 2, 5 and 10 years post hospital discharge.

There are 5 study centres taking part in this project enrolling in total a maximum of 160 patients.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
154
Inclusion Criteria
  • Age - 18 years minimum.
  • Sex - male and female.
  • General Health - the patient should be able to undergo surgery and participate in a follow-up program based upon physical examination and medical history.
  • Informed Consent - patient or patient's legal representative has signed a Patient Informed Consent form.
  • Indications - Diagnosis of disease or trauma in the affected joint, including cuff-tear arthropathy, failure of prior rotator cuff surgery and irreparable rotator cuff tears associated with loss of glenohumeral stability with the indication for total shoulder arthroplasty.
  • The deltoid muscle has to be intact in all 3 parts (clavicular, acromial as well as spinal).
Exclusion Criteria
  • Patient is skeletally immature.
  • Patient is pregnant.
  • Patient is unwilling or unable to cooperate in a follow-up program.
  • Patient shows one of the following medical conditions - Chronic fracture, Acute fracture, Axillary nerve lesion, Severe loss of humeral or glenoid bone, Paralysis of the deltoid muscle, Active Infection
  • Patient requires one of the following medical interventions - Implant Revision, Glenoid bone grafting, Autografts

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
Functional Performance10 years

Constant \& Murley Score. This evaluates clinical parameters such as range of motion, power, level of pain and functional ability. The score ranges from 0 - 100 with a higher score representing a better outcome.

Secondary Outcome Measures
NameTimeMethod
Survival (Kaplan-Meier)10 years

The Kaplan-Meier estimator is a non-parametric statistic used to estimate the survival function from lifetime data. It is used to measure the fraction of patients living (in this case without a revision surgery) for a certain amount of time after treatment. A higher score is a better outcome.

Trial Locations

Locations (5)

AZ Monica Antwerpen

🇧🇪

Antwerpen, Belgium

HELIOS ENDO-Klinik Hamburg

🇩🇪

Hamburg, Germany

Vitos Orthopädische Klinik Kassel

🇩🇪

Kassel, Germany

Uniklinik Balgrist

🇨🇭

Zürich, Switzerland

The Pennine Acute Hospital NHS Trust

🇬🇧

Manchester, United Kingdom

AZ Monica Antwerpen
🇧🇪Antwerpen, Belgium

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.